BIIB - יחס חוב להיוון בספרים Biogen Inc

Biogen Inc. is integrating ESG standards, having achieved climate neutrality and minimized toxic impact on the brain. This attracts top neuroscientists whose developments are supported by generous funding. The total debt-to-book capitalization ratio reflects the dynamics of the capital structure, where the value has stabilized at 0.47. However, the high cost of therapy is triggering protests from insurers, forcing the company to provide discounts.

This indicator reflects the ratio of total credit obligations to net asset value, allowing for an assessment of financial leverage and the risks of capital structure overheating. Analyzing the percentage of debt to book capitalization helps determine the resilience of Biogen Inc. (BIIB) to pressure from insurance companies that limit revenue from innovative drugs through mandatory discounts and strict price caps.